Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic Partners

Steve Holtzclaw, MD, MBA, is the CEO of U.S. Orthopaedic Partners, a position he assumed on January 1, 2024... Read more »

Interview with Richard Hughen, CEO of Linshom Medical

AI Summary Linshom Medical is the first company to deliver a wearable FDA-cleared respiratory profile device to... Read more »

Interview with Adam Low, CEO of SENTA Partners

Adam joined SENTA partners on May 6, 2019 as its Chief Executive Officer. In this role, Adam is responsible for the... Read more »

Gain exposure through our multi-channel news platform.

Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipeline

Krystal Biotech: VYJUVEK’s Blockbuster Potential In Gene Therapy For DEB

Providence To Invest $177 Million To Address Portland’s Most Urgent Health Care Challenge

An Update On Ascendis Pharma’s Path To Profitability

Summit Therapeutics’ Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer

2024’s Best & Worst States for Nurses – WalletHub Study

2024’s Best & Worst States for Children’s Health Care – WalletHub Study

Healthiest Cities in America (2024 Rankings) – WalletHub Study

Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues

2024’s Best & Worst States for Doctors – WalletHub Study

Pfizer: It’s Darkest Before The Dawn, Upgrading To ‘Strong Buy’

2024’s Most Overweight and Obese Cities in the U.S. – WalletHub Study

Pfizer Stock: It’s Time To Buy The Dip

Clear Secure: Stronger Travel Demand And Softer Dilution To Provide Momentum

2024’s States with the Best & Worst Dental Health – WalletHub Study

Pfizer: Victim Of Vaccine Side Effects